Categories
News

Molnupiravir and Drug Development at Emory

Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory

Categories
News

Liotta Group and DRIVE featured in New York Times

DRIVE seeks disease-fighting solutions via a different paradigm than big pharmaceutical industry. The New York Times features an opinion piece titled “In the Race for a Covid-19 Pill, a Little Lab Plays a Big Role.”Continue readingLiotta Group and DRIVE featured in New York Times

Categories
Community

A Conversation with Spandan Chennamadhavuni

While we are socially distant, we are working to bring the chemistry community closer together by sharing conversations with faculty, students, staff, and alumni. Interviews were conducted electronically and have been lightly edited for readability.Continue readingA Conversation with Spandan Chennamadhavuni

Categories
Community

A Conversation with Samantha Summer

While we are socially distant, we are working to bring the chemistry community closer together by sharing conversations with faculty, students, staff, and alumni. Interviews were conducted electronically and have been lightly edited for readability.Continue readingA Conversation with Samantha Summer

Categories
Spotlight

Dr. Jose Soria receives Emory Williams Distinguished Undergraduate Teaching Award

As Senior Lecturer for the Department of Chemistry, Dr. Jose Soria has taught lectures and laboratories ranging from introductory 100-level courses to 400-level advanced courses. His sees the classroom as a space for scientific discussion and the sharing of ideas, an approach which has been well-received by his students and undergraduate TAs. Dr. Soria‚Äôs dedication…Continue readingDr. Jose Soria receives Emory Williams Distinguished Undergraduate Teaching Award